Volume Alert - OREX 5.80 Orexigen Therapeutics $OREX Hit a

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 2:53 PM

Volume Alert - OREX 5.80 Orexigen Therapeutics $OREX Hit a high today of 6.02 Closing the day 10:30 at 5.80 -0.06 -1.02% With a day low of 5.77 and a total volume of 740,142.

OREX Recent Posts: http://investorshangout.com/Orexigen-Therapeu...REX-55007/

OREX Orexigen Therapeutics Recent Headline News

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind
at The Street - Fri Nov 14, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
OREX: 5.50 (-0.36), AMRN: 0.94 (-0.01), ICPT: 160.22 (+1.36), SPPI: 7.20 (-0.05), MNKD: 6.11 (-0.07)

Nasdaq stocks posting largest percentage increases
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ESCA: 13.28 (-0.24), IMDZ: 35.40 (-0.57), OLED: 27.50 (+0.30), FUEL: 18.50 (-0.70), CZR: 16.83 (+0.32), NTIC: 20.00 (-0.75), RESN: 7.12 (-0.07), OREX: 5.50 (-0.36), VBFC: 20.50 (-0.55), FLML: 13.14 (-0.25), ACHN: 13.88 (+0.39), RDI: 11.99 (+0.01), AMOT: 19.15 (-0.12), SUSQ: 13.09 (+0.03), RDIB: 12.00 (-0.04)

Most active Nasdaq-traded stocks
AP - Thu Nov 13, 12:28PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
BAXS: 0.03 (-0.03), FB: 74.86 (+0.61), CMCSK: 53.81 (-0.22), INTC: 33.92 (+0.24), OREX: 5.50 (-0.36), GILD: 101.74 (-2.46), ZNGA: 2.74 (+0.01), GRPN: 7.82 (+0.05), MSFT: 49.47 (-0.14), CMCSA: 53.98 (-0.32), SUSQ: 13.09 (+0.03), AAPL: 113.83 (+1.01), CSCO: 26.26 (+0.58)

5 Momentum Stocks Currently on the Move with More Potential Upside
at The Street - Thu Nov 13, 11:34AM CST
Achillion, Groupon, Orexigen, Rackspace and TG Therapeutics have had strong recent moves and are showing no sign of slowing.
OREX: 5.50 (-0.36), RAX: 43.69 (+0.36), ACHN: 13.88 (+0.39), TGTX: 13.92 (+0.05), GRPN: 7.82 (+0.05)

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
Lance Brofman - at Seeking Alpha - Thu Nov 13, 8:52AM CST

OREX: 5.50 (-0.36), HLF: 38.50 (+0.65), NVO: 44.06 (+0.04), VVUS: 3.25 (-0.01), AMGN: 156.86 (-3.99), GSK: 45.73 (+0.07), ARNA: 4.56 (-0.05)

Critical Alerts For Caesars Entertainment, Orexigen Therapeutics, Amazon.com, Toyota Motor and Amgen Released By InvestorsObserver
PR Newswire - Thu Nov 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for CZR, OREX, AMZN, TM and AMGN.
AMZN: 329.05 (+12.57), OREX: 5.50 (-0.36), AMGN: 156.86 (-3.99), TM: 119.62 (-0.20), CZR: 16.83 (+0.32)

Orexigen Therapeutics' (OREX) CEO Michael Narachi Presents at Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Nov 12, 2:28PM CST

OREX: 5.50 (-0.36)

Orexigen Therapeutics Continues To Rally
at The Street - Wed Nov 12, 12:02PM CST
Caesars Entertainment Corp (NASDAQ:CZR), Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Fossil Group Inc (NASDAQ:FOSL) reached midday with major gains. Taking tumbles midday are Altisource Portfolio...
OREX: 5.50 (-0.36), FOSL: 108.02 (-1.79), ASPS: 51.63 (-3.37), CZR: 16.83 (+0.32)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:45AM CST

LTBR: 1.97 (-0.08), ASPS: 51.63 (-3.37), AETI: 5.89 (+0.13), PLUG: 3.74 (-0.32), MOC: 1.88 (-0.07), CRDS: 2.65 (+0.08), STKL: 12.29 (+0.02), BIOC: 3.34 (-0.12), CZR: 16.83 (+0.32), MATX: 34.36 (+0.12), NTIC: 20.00 (-0.75), SDPI: 5.28 (+0.03), RESN: 7.12 (-0.07), OREX: 5.50 (-0.36), FLL: 1.21 (unch), VGGL: 2.72 (-0.20), CGG: 9.21 (+0.52), SUSQ: 13.09 (+0.03), SINO: 1.81 (unch), ELMD: 2.03 (+0.03)

Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST

OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), ARNA: 4.56 (-0.05)

Uptrend Call Working As Orexigen Therapeutics Stock Rises 23.6% (OREX)
Comtex SmarTrend(R) - Tue Nov 11, 11:04AM CST
SmarTrend identified an Uptrend for Orexigen Therapeutics (NASDAQ:OREX) on October 17th, 2014 at $4.16. In approximately 4 weeks, Orexigen Therapeutics has returned 23.56% as of today's recent price of $5.14.
OREX: 5.50 (-0.36)

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), AMAG: 33.77 (-0.47)

Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:25AM CST
Orexigen (OREX) was a big mover last session, with shares surging over 33% on the day.
BIIB: 306.04 (-11.94), OREX: 5.50 (-0.36), AMAG: 33.77 (-0.47), AFFX: 9.69 (unch)

Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 5.50 (-0.36), VVUS: 3.25 (-0.01), ARNA: 4.56 (-0.05)

Look for Shares of Orexigen Therapeutics to Potentially Pullback after Yesterday's 33.25% Rise
Comtex SmarTrend(R) - Mon Nov 10, 5:24PM CST
Orexigen Therapeutics (NASDAQ:OREX) traded in a range yesterday that spanned from a low of $4.04 to a high of $5.33. Yesterday, the shares gained 33.2%, which took the trading range above the 3-day high of $4.08 on volume of 15.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OREX: 5.50 (-0.36)

Market News: Apple,FireEye, Orexigen Therapeutics
at The Street - Mon Nov 10, 4:17PM CST
Oppenheimer market strategist, John Stoltzfus estimated that the S&P 500 could reach as 2,080 pointsThe stock markets in the United States ended the trading session higher as investors speculated that...
OREX: 5.50 (-0.36), FEYE: 33.76 (+0.42), AAPL: 113.82 (+1.00)

Dean Foods and Toll Brothers are big market movers
AP - Mon Nov 10, 3:48PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
DVAX: 14.62 (-0.98), OREX: 5.50 (-0.36), RYN: 26.01 (-0.12), MRK: 58.92 (-0.62), CMCSK: 53.81 (-0.22), DF: 16.68 (+0.01), TOL: 33.78 (+0.05), CMCSA: 53.98 (-0.32)

Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
at The Street - Mon Nov 10, 1:53PM CST
Orexigen Therapeutics (OREX) stock is up after the company said the European Union review of its drug is progressing, as it reported better than expected third quarter earnings this morning.
OREX: 5.50 (-0.36)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leatt Gears Up for Q3 Results Conference Call

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Why Retaining Wall Drainage Can’t Be an Afterthought

The overlooked hero in wall longevity People might think building a retaining wall is just stacking stones or pouring concrete, but that's only part of the story. According to Justin Hundich, our go-to guy on landscape and drainage matters, there's way more at play than meets the eye. If you ignore drainage, you're steaming toward disaster, my friend—no two ways about...

Painter Capri: Comfort Revolution or Just Hype?

A New Hope for Painters' Comfort? Alright, here we go. Some folks out there in the land of ladders and rollers have had it with wearing uncomfortable, stifling work gear every day. Enter the PAINTER CAPRI. Designed by an inventive spirit from Homer Glen, Illinois, these pants aim to be both breathable and functionally sound—for painters, electricians, and other gritty...

Global Museum of Illusions Comes to San Francisco

Illusions on Market Street The Global Museum of Illusions, the fast-growing sensation in private museums, is setting its sights on San Francisco with a new location opening on Market Street this November 13. They're dangling a juicy 50% off presale ticket offer for the early birds. A Mind-Bending Experience This museum isn't your run-of-the-mill art gallery or historical...

Orthodontic Treatment: Timelines and Expert Insights

Getting Straight to the Point: Orthodontic Timelines Remember that time your teen self thought braces would be over in a flash? Yeah, well, Dr. Judith Okun might have a few words on that. When it comes to braces, you better buckle up for the long haul. Most folks are looking at a solid two years, give or take. No magic shortcuts here, just solid orthodontic science. The...

Stavian Group Eyes AI-Driven Southeast Asia Growth

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

EZ MOUSE Revolutionizes Multi-Device Computing Control

A New Dawn for Multi-Device Users Sometimes, the best ideas are born from sheer frustration. Take this EZ MOUSE invention, for example. Some creative soul from Sun Prairie, Wisc. had enough of juggling multiple computer mice for their array of desktops and laptops. In response, they hatched the idea for a patent-pending gadget that aims to streamline operations across...

Specialty1 Partners: Top Workplaces Triumph in 2026

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...

Mesh Security Bolsters Team with Five Cybersecurity Experts

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Outpace SEO Claims Impressive 3.7x Client ROI Boost

Outpace SEO's Bold Promise: A Data-Driven Success The SEO game isn't for the faint-hearted. You either step up or get left behind. Outpace SEO, hailing from Oklahoma City, has decided to set their own rules with a boastful claim of a 3.7x return on investment (ROI) for their clients. That kind of promise sets the bar high, and it's tied to their data-driven approach to...